Status:

ACTIVE_NOT_RECRUITING

Hispanic Adapted and Culturally Relevant Exercising Together

Lead Sponsor:

University of Arizona

Conditions:

Neoplasms

Prostate Cancer

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

The purpose of this study is to determine the feasibility and effects of an adapted Exercising Together, a partnered resistance training program, on the physical and mental health of prostate cancer s...

Eligibility Criteria

Inclusion

  • Phase 1:
  • Inclusion Criteria (Survivor only):
  • Self-identifies as Hispanic
  • Histologically confirmed prostate cancer diagnosis (self-report)
  • Completed primary treatment at least 6 weeks prior at time of enrollment
  • Has an identified caregiver in any relationship role (e.g., spouse, sibling, parent, friend) who can participate with them.
  • Inclusion Criteria (Caregivers):
  • 1\. Identifies as an individual (e.g., family member or friend) who provides unpaid care or support to a participating prostate cancer survivor.
  • Inclusion Criteria (Survivors and Caregivers):
  • ≥18 years of age
  • Understands (ability to read and speak) English or Spanish and able to provide informed consent
  • Meets the American College of Sports Medicine pre-participation screening criteria for exercise
  • Ability to ambulate (with or without assistive devices)
  • Willing to attend study group exercise classes online, complete remote assessments, and answer online surveys
  • Has access to a mobile device with camera and internet.
  • Able to participate in classes at same time as other participating member.
  • Exclusion Criteria:
  • Cognitive difficulties that preclude answering the survey questions, participating in the exercise classes or performance tests, or providing informed consent as determined by the professional opinion of the Principal Investigator
  • A medical condition, movement or neurological disorder, or medication use that contraindicates participation in moderate intensity exercise or poses a significant safety concern/risk for the well-being of the participant (e.g., declared pregnancy, poorly controlled diabetes, recent cardiac event, neuromuscular disease, untreated orthostatic hypertension, recent surgery, acute hernia, acute rheumatoid arthritis, severe memory disorders, severe balance disorder, severe hearing or vision impairment)
  • Knowingly unable to attend \>75% of the intervention classes due to conflict with the designated time of day, days of the week, and/or location for the exercise class which they initially enrolled
  • Incapable of providing informed consent, answering survey questions, participating in the intervention, and following directions during performance testing when English or Spanish language is used
  • Unable to be in the same location with participating member during remote exercise classes and performance testing and/or insufficient internet connectivity to support required videoconferencing software
  • Phase 2:
  • Inclusion Criteria (Survivor only):
  • Histologically confirmed cancer diagnosis (self-report)
  • Completed primary treatment at least 6 weeks prior at time of enrollment
  • Has an identified caregiver in any relationship role (e.g., spouse, sibling, parent, friend) who can participate with them.
  • Inclusion Criteria for Caregivers remains the same as Phase 1 Exclusion Criteria remain the same as Phase 1

Exclusion

    Key Trial Info

    Start Date :

    November 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2025

    Estimated Enrollment :

    58 Patients enrolled

    Trial Details

    Trial ID

    NCT06018311

    Start Date

    November 1 2023

    End Date

    December 31 2025

    Last Update

    October 14 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Arizona Cancer Center

    Tucson, Arizona, United States, 85719